Redefining clinical trials: the age of personalized medicine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22424218.
- Also identified by DOI 10.1016/j.cell.2012.02.041.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The triumph of personalized cancer therapeutics in recent years is prompting some oncologists to rethink clinical trial design; other researchers have different priorities for trial reform.
Medical subject headings
- Clinical Trials as Topic
- Neoplasms
- Precision Medicine